Literature DB >> 2256510

Isolation and characterization of the gene from a human genome encoding 17 beta-estradiol dehydrogenase: a comparison of Jar and BeWo choriocarcinoma cell lines.

C A Long1, G S Bauer, M E Lowe, A W Strauss, M J Gast.   

Abstract

17-beta-Estradiol dehydrogenase is required for the enzymatic interconversion of estradiol and its weaker related sex steroid, estrone. We isolated and sequenced a complementary deoxyribonucleic acid clone for 17 beta-estradiol dehydrogenase from the BeWo choriocarcinoma cell line. Comparison of the BeWo complementary deoxyribonucleic acid sequence to a previously derived placental complementary deoxyribonucleic acid sequence yields greater than 98% homology. We also isolated the gene for 17 beta-estradiol dehydrogenase from the Jar human choriocarcinoma cell line and elucidated its primary nucleic acid structure. Significant differences in the Jar-deduced complementary deoxyribonucleic acid sequence clearly differentiate it from both the human placental and BeWo forms of 17 beta-estradiol dehydrogenase, indicating the existence of two genes for 17 beta-estradiol dehydrogenase in the human genome. Evaluation of 17 beta-estradiol dehydrogenase gene expression in BeWo and Jar cells was compared with expression in luteinized granulosa cells. Messenger ribonucleic acid for human placental 17 beta-estradiol dehydrogenase was identified in all three cell types as a 1.3 kilobase band on Northern blot analysis. A second messenger ribonucleic acid species measuring 2.1 kilobase was abundantly present in the granulosa cells. Whether these two species of messenger ribonucleic acid are involved in the regulation of the estradiol dehydrogenase genes is yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256510     DOI: 10.1016/0002-9378(90)90783-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  1 in total

1.  Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.

Authors:  Liora Madar-Shapiro; Ido Karady; Alla Trahtenherts; Argryo Syngelaki; Ranjit Akolekar; Liona Poon; Ruth Cohen; Adi Sharabi-Nov; Berthold Huppertz; Marei Sammar; Kata Juhasz; Nandor Gabor Than; Zoltan Papp; Roberto Romero; Kypros H Nicolaides; Hamutal Meiri
Journal:  Fetal Diagn Ther       Date:  2017-07-21       Impact factor: 2.587

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.